<DOC>
	<DOCNO>NCT01871467</DOCNO>
	<brief_summary>Previous study demonstrate deficiency blood dendritic cell patient kidney disease associate development viral infection kidney transplantation . We plan test ability sargramostim increase blood dendritic cell level patient kidney disease hope develop new therapy prevent viral infection kidney transplantation .</brief_summary>
	<brief_title>Sargramostim Myeloid Dendritic Cell Deficiency</brief_title>
	<detailed_description />
	<criteria>Age &gt; 18 year &lt; 80 year diagnosis end stage renal disease currently undergoing outpatient hemodialysis ( HD ) one Johns Hopkins Universityaffiliated HD unit Age &lt; 18or &gt; 80years History nonadherence prescribe HD treatment Active drug heavy alcohol use ( define &gt; 4 drinks/day ) Pregnancy breast feed Active infection ( bacterial viral ) clinically significant infection within past three month ( e.g . require hospitalization , judge PI ) Active malignancy ( exception excise nonmetastatic basal cell carcinoma squamous cell carcinoma skin , adequately treat pre invasive cervical cancer situ ) Unstable cardiovascular status ( angina , arrhythmias , congestive heart failure etc ... ) History liver disease ( defined diagnosis uncompensated cirrhosis ) â€¢ History lung disease ( include moderatesevere chronic obstructive pulmonary disease , interstitial lung disease , asthma ) Known hypersensitivity yeastderived product Hemoglobin &lt; 10 g/dL hematocrit &lt; 30 % . Abnormal white blood cell ( WBC ) count baseline ( &lt; 3 &gt; 12 x 10 cells/mm ) Treatment WBC growth factor ( GCSF GMCSF ) immunosuppressive medication ( tacrolimus , cyclosporine , mycophenolate , azathioprine , corticosteroid , chlorambucil , cyclophosphamide ) within 4 week study ( erythropoiesisstimulating agent allow ) Treatment lithium within 4 week study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>